Register for the Webinar, Time: August 14 at 10:00 AM EST | 4 PM CEST
New biopharmaceutical drug products that alter and even save lives can be very profitable for their developers. They are, however, costly to develop and represent significant investment, particularly at the end of the manufacturing process. For this reason, safe cost-effective frozen storage and transport are critical, especially as drugs transition from R&D through clinical trial and to higher volume production.
In this webinar, Mike Johnson, Entegris Director R&D Engineering, and Johannes Kirchmair, CEO/Founder of Single Use Support (SUS), present single-use bag system technologies for freeze/thaw applications in bulk drug substance (BDS) manufacturing.
Transitioning to more efficient, cost-effective, single-use solutions can help biopharmaceutical manufacturers hit performance targets at high yields.
- Mike Johnson
Director R&D Engineering
- Johannes Kirchmair Read Bio
Single Use Support GmbH